Incorporating molecular profiling into endometrial cancer management requires prospective studies

Int J Gynecol Cancer. 2021 Jun;31(6):944-945. doi: 10.1136/ijgc-2021-002705. Epub 2021 May 7.

Frédéric Amant^{1

2

3}, W Glenn McCluggage⁴, Henrica M J Werner⁵, Jenneke C Kasius³, Camilla Krakstad⁶, Johanna Pijnenborg⁷

¹ Department of Oncology, KU Leuven, Leuven, Belgium frederic.amant@uzleuven.be.
² Netherlands Cancer Institute, Amsterdam, the Netherlands.
³ Amsterdam University Medical Centres, Amsterdam, the Netherlands.
⁴ Pathology, Belfast Health and Social Care Trust, Belfast, Belfast, UK.
⁵ Department of Obstetrics and Gynaecology, GROW, Maastricht University School for Oncology & Developmental Biology, Maastricht, Limburg, Netherlands.
⁶ Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway.
⁷ Department of Obstetrics & Gynaecology, Radboudumc, Nijmegen, Gelderland, Netherlands.

No abstract available

Keywords: endometrium.

Publication types